VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX)
CUSIP: 92532F100
Q3 2014 13F Holders as of 30 Sep 2014
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 254,691,824
- Total 13F shares
- 233,322,706
- Share change
- +6,164,141
- Total reported value
- $26,203,942,928
- Put/Call ratio
- 143%
- Price per share
- $112.31
- Number of holders
- 424
- Value change
- +$763,613,344
- Number of buys
- 217
- Number of sells
- 176
Quarterly Holders Quick Answers
What is CUSIP 92532F100?
CUSIP 92532F100 identifies VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Related Filing Research
- Latest 13F filings for newly reported positions.
- Latest Schedule 13D/13G reports for ownership changes outside 13F cadence.
- Latest 10-Q/10-K reports for financial context tied to this issuer.
- Recent insider transactions for executive and insider activity.
- SEC investors directory and top value investors for manager drilldown.
- Back to full security ownership history.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 92532F100:
Top shareholders of VRTX - VERTEX PHARMACEUTICALS INC / MA - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| Capital World Investors |
13F
|
Company |
10%
|
26,382,177
|
$2,497,865,000 | — | 30 Jun 2014 | |
| VANGUARD GROUP INC |
13F
|
Company |
6.6%
|
16,702,746
|
$1,581,415,000 | — | 30 Jun 2014 | |
| WELLINGTON MANAGEMENT GROUP LLP |
13F
|
Company |
6.5%
|
16,461,104
|
$1,558,537,000 | — | 30 Jun 2014 | |
| PRICE T ROWE ASSOCIATES INC /MD/ |
13F
|
Company |
5.4%
|
13,866,784
|
$1,312,907,000 | — | 30 Jun 2014 | |
| FMR LLC |
13F
|
Company |
5.1%
|
13,026,543
|
$1,233,353,000 | — | 30 Jun 2014 | |
| JENNISON ASSOCIATES LLC |
13F
|
Company |
4.7%
|
11,865,009
|
$1,123,379,000 | — | 30 Jun 2014 | |
| STATE STREET CORP |
13F
|
Company |
3.9%
|
9,961,924
|
$943,193,000 | — | 30 Jun 2014 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
3.8%
|
9,635,998
|
$912,335,000 | — | 30 Jun 2014 | |
| Clearbridge Investments, LLC |
13F
|
Company |
3%
|
7,549,418
|
$714,779,000 | — | 30 Jun 2014 | |
| AMERIPRISE FINANCIAL INC |
13F
|
Company |
2.8%
|
7,078,575
|
$670,196,000 | — | 30 Jun 2014 | |
| BlackRock Institutional Trust Company, N.A. |
13F
|
Company |
2.4%
|
6,062,597
|
$574,007,000 | — | 30 Jun 2014 | |
| BlackRock Fund Advisors |
13F
|
Company |
2.3%
|
5,791,053
|
$548,297,000 | — | 30 Jun 2014 | |
| WADDELL & REED FINANCIAL INC |
13F
|
Company |
1.5%
|
3,808,800
|
$360,617,000 | — | 30 Jun 2014 | |
| Bank of New York Mellon Corp |
13F
|
Company |
1.3%
|
3,325,673
|
$314,875,000 | — | 30 Jun 2014 | |
| LOOMIS SAYLES & CO L P |
13F
|
Company |
1.2%
|
3,036,552
|
$287,501,000 | — | 30 Jun 2014 | |
| Invesco Ltd. |
13F
|
Company |
1.2%
|
3,005,091
|
$284,521,000 | — | 30 Jun 2014 | |
| ADAGE CAPITAL PARTNERS GP, L.L.C. |
13F
|
Company |
1.2%
|
2,967,367
|
$280,950,000 | — | 30 Jun 2014 | |
| NORTHERN TRUST CORP |
13F
|
Company |
1.2%
|
2,937,473
|
$278,119,000 | — | 30 Jun 2014 | |
| GOLDMAN SACHS GROUP INC |
13F
|
Company |
1.1%
|
2,819,755
|
$266,974,000 | — | 30 Jun 2014 | |
| LAZARD ASSET MANAGEMENT LLC |
13F
|
Company |
1%
|
2,627,189
|
$248,740,000 | — | 30 Jun 2014 | |
| OppenheimerFunds, Inc. |
13F
|
Company |
0.9%
|
2,300,882
|
$217,848,000 | — | 30 Jun 2014 | |
| DEUTSCHE BANK AG\ |
13F
|
Company |
0.86%
|
2,200,437
|
$208,332,000 | — | 30 Jun 2014 | |
| BlackRock Group LTD |
13F
|
Company |
0.8%
|
2,027,101
|
$191,926,000 | — | 30 Jun 2014 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.68%
|
1,740,295
|
$164,673,000 | — | 30 Jun 2014 | |
| NORGES BANK |
13F
|
Company |
0.6%
|
1,540,270
|
$145,833,000 | — | 30 Jun 2014 | |
| FRANKLIN RESOURCES INC |
13F
|
Company |
0.58%
|
1,471,758
|
$139,346,000 | — | 30 Jun 2014 | |
| BB BIOTECH AG |
13F
|
Company |
0.55%
|
1,404,445
|
$132,973,000 | — | 30 Jun 2014 | |
| ALLIANCEBERNSTEIN L.P. |
13F
|
Company |
0.54%
|
1,378,620
|
$130,528,000 | — | 30 Jun 2014 | |
| UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC |
13F
|
Company |
0.52%
|
1,333,117
|
$126,219,000 | — | 30 Jun 2014 | |
| BLACKROCK ADVISORS LLC |
13F
|
Company |
0.44%
|
1,131,111
|
$107,094,000 | — | 30 Jun 2014 | |
| TIAA CREF INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.44%
|
1,121,536
|
$106,187,000 | — | 30 Jun 2014 | |
| SECTORAL ASSET MANAGEMENT INC |
13F
|
Company |
0.42%
|
1,079,464
|
$102,204,000 | — | 30 Jun 2014 | |
| PUTNAM INVESTMENTS LLC |
13F
|
Company |
0.39%
|
994,555
|
$94,164,000 | — | 30 Jun 2014 | |
| Legal & General Group Plc |
13F
|
Company |
0.39%
|
989,865
|
$93,720,000 | — | 30 Jun 2014 | |
| FIRST TRUST ADVISORS LP |
13F
|
Company |
0.39%
|
986,152
|
$93,369,000 | — | 30 Jun 2014 | |
| Point72 Asset Management, L.P. |
13F
|
Company |
0.37%
|
934,700
|
$88,497,000 | — | 30 Jun 2014 | |
| MANAGED ACCOUNT ADVISORS LLC |
13F
|
Company |
0.37%
|
932,541
|
$88,293,000 | — | 30 Jun 2014 | |
| D. E. Shaw & Co., Inc. |
13F
|
Company |
0.36%
|
924,025
|
$87,486,000 | — | 30 Jun 2014 | |
| GUGGENHEIM CAPITAL LLC |
13F
|
Company |
0.35%
|
884,339
|
$83,730,000 | — | 30 Jun 2014 | |
| AMUNDI ASSET MANAGEMENT US, INC. |
13F
|
Company |
0.33%
|
850,152
|
$80,492,000 | — | 30 Jun 2014 | |
| HOLLAND CAPITAL MANAGEMENT LLC |
13F
|
Company |
0.3%
|
770,187
|
$72,921,000 | — | 30 Jun 2014 | |
| CALIFORNIA PUBLIC EMPLOYEES RETIREMENT SYSTEM |
13F
|
Company |
0.28%
|
719,994
|
$68,169,000 | — | 30 Jun 2014 | |
| NEW YORK STATE COMMON RETIREMENT FUND |
13F
|
Company |
0.28%
|
715,425
|
$67,736,000 | — | 30 Jun 2014 | |
| BNP PARIBAS FINANCIAL MARKETS |
13F
|
Company |
0.27%
|
677,915
|
$64,169,811 | — | 30 Jun 2014 | |
| CREDIT SUISSE AG/ |
13F
|
Company |
0.27%
|
677,521
|
$64,147,000 | — | 30 Jun 2014 | |
| WELLS FARGO & COMPANY/MN |
13F
|
Company |
0.26%
|
673,158
|
$63,736,000 | — | 30 Jun 2014 | |
| abrdn Investment Management Ltd |
13F
|
Company |
0.23%
|
593,339
|
$56,175,000 | — | 30 Jun 2014 | |
| Sumitomo Mitsui Trust Group, Inc. |
13F
|
Company |
0.22%
|
549,282
|
$52,006,000 | — | 30 Jun 2014 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.22%
|
547,927
|
$51,878,000 | — | 30 Jun 2014 | |
| Tekla Capital Management LLC |
13F
|
Company |
0.21%
|
540,944
|
$51,217,000 | — | 30 Jun 2014 |
Institutional Holders of VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) as of Q3 2014
As of 30 Sep 2014,
VERTEX PHARMACEUTICALS INC / MA - Common Stock (VRTX) was held by
424 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
233,322,706 shares.
The largest 10 holders included
Capital World Investors, WELLINGTON MANAGEMENT CO LLP, VANGUARD GROUP INC, PRICE T ROWE ASSOCIATES INC /MD/, FMR LLC, JPMORGAN CHASE & CO, JENNISON ASSOCIATES LLC, State Street Corp, Ameriprise Financial Inc, and Clearbridge Investments, LLC.
This page lists
424
institutional shareholders reporting positions in this security
for the Q3 2014 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2014 vs Q2 2014 Across Filers
Q2 2014 holders
405
Q3 2014 holders
424
Holder diff
19
| Investor | Q2 2014 Shares | Q3 2014 Shares | Share Diff | Share Chg % | Q2 2014 Value $ | Q3 2014 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.